Anderson S, Graham R M, Brater D C
Am J Med Sci. 1985 Jul;290(1):15-8. doi: 10.1097/00000441-198507000-00004.
We tested our clinical impression that black hypertensives in our clinic population responded better to alpha-adrenergic blocking agents (clonidine and prazosin) than to beta-adrenergic blockers (atenolol, nadolol and propranolol). Compared to no effect from eight weeks of therapy with beta-blockers, clonidine significantly decreased erect mean arterial pressure (MAP) when assessed weekly for four weeks (p = 0.027 to 0.046). However, the decrease in supine MAP was not significant. The effects of prazosin were more modest. Supine MAP was significantly less than with beta-blockade (p = 0.032) at two weeks but not at four weeks and decrements in erect MAP were not significant. In this preliminary study, black hypertensives appeared to be more responsive to alpha-adrenergic antagonists than to beta-blockers, with clonidine more effective than prazosin. Elucidation of possible mechanisms of the difference and of its clinical importance warrant further study.
我们检验了我们的临床印象,即在我们诊所的人群中,黑人高血压患者对α-肾上腺素能阻滞剂(可乐定和哌唑嗪)的反应比对β-肾上腺素能阻滞剂(阿替洛尔、纳多洛尔和普萘洛尔)更好。与β受体阻滞剂治疗八周无效果相比,可乐定在四周内每周评估时显著降低直立平均动脉压(MAP)(p = 0.027至0.046)。然而,仰卧位MAP的降低并不显著。哌唑嗪的作用较温和。仰卧位MAP在两周时显著低于β受体阻滞剂组(p = 0.032),但四周时无差异,直立MAP的降低也不显著。在这项初步研究中,黑人高血压患者似乎对α-肾上腺素能拮抗剂比对β受体阻滞剂更敏感,可乐定比哌唑嗪更有效。阐明这种差异的可能机制及其临床重要性值得进一步研究。